Functional analysis indicates that both CD22 wild type and splice variants are involved in the regulation of the spontaneous proliferation of malignant T cells suggesting a role for CD22 in the pathogenesis of CTCL. The gene discussed is CD22; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.